Organon & Co. (NYSE:OGN) vs. Aeon Global Health (OTCMKTS:AGHC) Financial Comparison

Organon & Co. (NYSE:OGN) and Aeon Global Health (OTCMKTS:AGHC) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability.

Analyst Recommendations

This is a breakdown of current ratings for Organon & Co. and Aeon Global Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organon & Co.	2	2	1	1	2.17
Aeon Global Health	0	0	0	0	0.00

Organon & Co. currently has a consensus target price of $13.00, suggesting a potential upside of 92.17%. Given Organon & Co.’s stronger consensus rating and higher possible upside, research analysts plainly believe Organon & Co. is more favorable than Aeon Global Health.

Insider and Institutional Ownership

77.4% of Organon & Co. shares are owned by institutional investors. 1.4% of Organon & Co. shares are owned by company insiders. Comparatively, 11.5% of Aeon Global Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Organon & Co. and Aeon Global Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organon & Co.	$6.40 billion	0.27	$864.00 million	$2.69	2.51
Aeon Global Health	N/A	N/A	N/A	N/A	N/A

Organon & Co. has higher revenue and earnings than Aeon Global Health.

Profitability

This table compares Organon & Co. and Aeon Global Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Organon & Co.	11.15%	163.88%	6.99%
Aeon Global Health	N/A	N/A	N/A

Summary

Organon & Co. beats Aeon Global Health on 9 of the 10 factors compared between the two stocks.

About Organon & Co.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

About Aeon Global Health

AEON Global Health Corp. is a growth oriented provider of personalized, actionable medical informatics, and telemedicine. It offers a comprehensive menu of diagnostic and laboratory developed assays, as well as interpretive data for a range of inherited conditions. The company was founded by Hanif A. Roshan and Shawn Desai in August 1985 and is headquartered in Gainesville, GA.